| abstract |
REFERS TO THE USE OF (5-ARIL-1,2,4-TIADIAZOL) -3-IL THIOUREA DERIVATIVE, OR (5-ARYL-1,2,4-THADIAZOLE) -3-IL UREA DERIVATIVE OF FORMULA , WHERE: X IS O, S; R IS H, C1-C3 ALKYL; n IS 1-4; R1 IS H, C1-C7 ALKYL, Cl, Br, F, OXYCHLORO, ALCOXY O (CH2) and (CH3); and ES 1-6; AT LEAST 3 WEEKS; BEING THE ADMINISTRATION DOSE FROM 1mg / kg TO 1OOOO mmg / kg. ALSO REFERS TO THE USE OF AZIDOVUDINE (AZT), LAMIVUDINE (TC-3), PROTEASE INHIBITORS. THE COMPOSITION IS PRESENTED IN SOLID FORM AND INCLUDES A CARRIER SUCH AS SUCROSA LACTOSE, GELATINE, AGAR OR IT IS PRESENT IN LIQUID FORM SUCH AS AQUEOUS SOLUTIONS, ALCOHOLIC SOLUTIONS, EMULSIONS, SUSPENSIONS, SUSPENSIONS, AND NON-EFFECTED PREPENSIONS REBUILDING SUSPENSIONS. THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF VIRAL INFECTIONS SUCH AS HIV, HEPATITIS |